Vyleesi: An Evidence-Based Guide for Patients

Vyleesi is a prescription medicine used to treat acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. It may improve sexual desire for some patients, but it has specific limits, side effects, and safety considerations that should be reviewed with a qualified clinician.

Overview: What Vyleesi Is and Who It Is For

Vyleesi is a prescription medicine whose active ingredient is bremelanotide. It is approved for the treatment of acquired, generalized hypoactive sexual desire disorder, often called HSDD, in certain premenopausal women. In simple terms, it is intended for women who previously had a satisfactory level of sexual desire and then developed a persistent drop in desire that causes distress and is not limited to one partner, one situation, or a temporary life event.

Vyleesi does not work as a general “libido booster” for everyone. It is not meant for sexual problems caused mainly by another medical condition, a psychiatric condition, severe relationship difficulties, or the effects of a medicine or substance. It is also not approved for use in postmenopausal women or in men.

Because sexual desire is influenced by the body, emotions, relationships, and life circumstances, the decision to use Vyleesi usually follows a careful clinical conversation. Many people benefit from evaluating the full picture first, including stress, sleep, mood, hormone changes, pain with sex, and medication side effects. This broader approach helps make treatment safer and more appropriate.

How Vyleesi Works and What Results to Expect

Vyleesi acts on pathways in the brain involved in sexual desire. It is not a hormone treatment and it does not work the same way as medicines used for erectile dysfunction. Instead of increasing blood flow directly, it is thought to influence receptors involved in sexual interest and response.

The medicine is used as needed before anticipated sexual activity rather than as a daily treatment. Some women notice improvement in desire or a reduction in distress related to low desire, while others do not feel a meaningful benefit. Results can vary, and treatment is usually reassessed after a trial period to determine whether it is helping enough to continue.

It is important to set realistic expectations. Vyleesi does not guarantee sexual desire, arousal, or orgasm, and it does not resolve every factor that can affect intimacy. For many patients, the best outcomes come from combining medical evaluation with attention to relationship health, emotional well-being, and other contributing symptoms such as pelvic pain or vaginal discomfort.

Who May Be a Candidate for Vyleesi

A person may be a candidate for Vyleesi if she is premenopausal, has acquired generalized HSDD, feels bothered by the change in sexual desire, and does not have another clearer explanation for the symptom. A clinician will usually ask when the problem began, whether desire was previously higher, and whether the issue happens across settings rather than in only one relationship or circumstance.

The assessment may also look for conditions that can mimic or contribute to low desire. These can include depression, anxiety, chronic pain, sleep problems, hormonal changes, thyroid disorders, medication effects, and sexual pain disorders. In some cases, low desire may overlap with issues such as vaginismus or vaginal dryness, where discomfort during intimacy reduces interest over time.

Before prescribing Vyleesi, a doctor will also review heart and blood pressure history. The medicine can raise blood pressure temporarily and may not be appropriate for people with uncontrolled high blood pressure or known cardiovascular disease. A thorough medication review is also important to check for possible interactions and to make sure treatment goals are clear.

How Vyleesi Is Used

Vyleesi is given as an injection under the skin, usually in the abdomen or thigh, before anticipated sexual activity. Patients should use it exactly as prescribed and follow the product instructions carefully. A healthcare professional can explain proper injection technique, safe handling, and how often it may be used.

Because it is taken as needed, planning and timing matter. Patients should not change the amount or frequency on their own, even if they feel the effect is too weak or too strong. If nausea or other side effects occur, the prescribing clinician may review whether the medicine is still a good fit.

When sexual symptoms are part of a more complex picture, treatment may involve more than one strategy. Depending on the cause, a doctor may recommend counseling, pelvic floor care, hormone evaluation, or treatment for associated gynecologic conditions. In selected cases, management may also include care related to gynecology evaluation or reproductive and hormonal assessment if broader reproductive health concerns are part of the discussion.

Side Effects, Risks, and Safety Considerations

The most commonly discussed side effect of Vyleesi is nausea, which can sometimes be significant, especially after the first dose. Other possible side effects include flushing, headache, vomiting, fatigue, dizziness, and reactions where the injection is given. Some people also notice temporary skin darkening, particularly with repeated use.

Vyleesi can cause a temporary increase in blood pressure and a decrease in heart rate after dosing. For this reason, it is generally avoided in people with uncontrolled hypertension or certain forms of cardiovascular disease. Anyone with chest pain, severe shortness of breath, fainting, or a severe reaction after use should seek urgent medical help.

Not every side effect requires stopping treatment, but persistent or troublesome symptoms should be reported. A clinician may advise discontinuing Vyleesi if it does not meaningfully improve symptoms after an adequate trial. Patients should also mention all prescription medicines, over-the-counter products, and supplements they use so that safety can be reviewed more fully.

• Common concerns: nausea, flushing, headache, injection-site discomfort
• Safety review: blood pressure, heart history, medication interactions
• Reassessment: continue only if there is clear benefit

A Broader Approach to Low Sexual Desire

Low sexual desire is often shaped by multiple factors, so medication is only one part of care. Stress, relationship strain, body image concerns, depression, anxiety, sleep loss, and prior negative sexual experiences can all contribute. A respectful, nonjudgmental evaluation can help identify what is most relevant for each person.

Physical symptoms are also important. Pain during sex, vaginal dryness, pelvic floor tension, fatigue, and chronic illness may reduce desire indirectly by making intimacy uncomfortable or emotionally difficult. If the symptom pattern suggests a gynecologic issue, patients may benefit from assessment related to ovarian cysts or other pelvic conditions when clinically appropriate.

Supportive care may include sex therapy, couples counseling, mental health treatment, improved sleep habits, exercise, review of antidepressants or other medicines that affect libido, and treatment of painful sex. This wider view can prevent oversimplifying a deeply personal health concern and often leads to more sustainable improvement.

When to Seek Medical Care

A person should speak with a doctor if low sexual desire is persistent, causes distress, or affects quality of life or relationships. Medical care is also important when low desire begins suddenly, follows a new medication, or occurs along with symptoms such as pelvic pain, irregular bleeding, severe mood changes, or vaginal discomfort.

Prompt medical advice is especially important after using Vyleesi if there is severe nausea and vomiting, a strong allergic-type reaction, chest discomfort, marked dizziness, or symptoms that suggest a significant rise in blood pressure. These situations need professional evaluation rather than self-management.

If low sexual desire is connected with ongoing gynecologic or reproductive symptoms, a multidisciplinary review can be helpful. Near the end of the care pathway, patients seeking coordinated international care may wish to know that Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat women’s health concerns for international patients, including evaluation for relevant gynecologic care when needed.

Frequently asked questions

What is Vyleesi used for?

Vyleesi is used to treat acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. It is meant for women with persistently low sexual desire that causes distress and is not mainly explained by another medical, psychiatric, relationship, or medication-related cause.

Is Vyleesi the same as hormone therapy?

No. Vyleesi is not a hormone treatment. Its active ingredient, bremelanotide, works on brain pathways involved in sexual desire rather than replacing estrogen or testosterone.

How quickly does Vyleesi work?

Vyleesi is used before anticipated sexual activity, but individual response varies. Some patients notice benefit during a treatment trial, while others may not experience meaningful improvement and may need reassessment with their doctor.

What are the most common side effects of Vyleesi?

Common side effects include nausea, flushing, headache, vomiting, fatigue, dizziness, and injection-site reactions. Many side effects are temporary, but persistent or severe symptoms should be discussed with a healthcare professional.

Who should not use Vyleesi?

Vyleesi may not be suitable for people with uncontrolled high blood pressure or certain cardiovascular conditions. It is also not approved for men or for postmenopausal women, and it is not intended for low desire caused mainly by other medical or psychiatric conditions or by medicines.

Can Vyleesi cure low libido?

No medicine can address every cause of low libido. Vyleesi may help some women with a specific diagnosis, but low sexual desire often has emotional, relational, hormonal, and physical contributors that may also need attention.

References

• U.S. Food and Drug Administration
• American College of Obstetricians and Gynecologists
• International Society for the Study of Women's Sexual Health
• MedlinePlus
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.